Your browser doesn't support javascript.
loading
Treatment patterns and outcomes for primary uterine leiomyosarcoma with synchronous isolated lung metastases: A National Cancer Database study of primary resection and metastasectomy.
Istl, Alexandra C; Desravines, Nerlyne; Nudotor, Richard; Stone, Rebecca; Greer, Jonathan B; Meyer, Christian F; Johnston, Fabian M.
Afiliação
  • Istl AC; Division of Surgical Oncology, Medical College of Wisconsin, United States.
  • Desravines N; Division of Gynecologic Oncology, Johns Hopkins Hospital, United States.
  • Nudotor R; Department of Surgery, Anne Arundel Medical Center, United States.
  • Stone R; Division of Gynecologic Oncology, Johns Hopkins Hospital, United States.
  • Greer JB; Division of Surgical Oncology, Johns Hopkins Hospital, United States.
  • Meyer CF; Division of Medical Oncology, Johns Hopkins Hospital, United States.
  • Johnston FM; Division of Surgical Oncology, Johns Hopkins Hospital, United States.
Gynecol Oncol Rep ; 51: 101308, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38174328
ABSTRACT

Background:

One third of patients with uterine leiomyosarcomas (uLMS) present with distant metastases. Current guidelines do not include recommendations around surgery for metastatic uLMS. Patients with distant metastases commonly receive primary tumor resection for symptoms and so oncologic outcomes after surgery warrant exploration. We describe treatment patterns and outcomes for uLMS patients with synchronous isolated lung metastases (SILM).

Methods:

This retrospective analysis of the National Cancer Database identified patients with uLMS and SILM. Patients with non-pulmonary metastases were excluded. We collected demographic, disease, and treatment characteristics and assessed clinicopathologic factors associated with the receipt of surgery on multivariate regression. Median, 1-year, and 5-year overall survival (OS) across treatment approaches were compared using Kaplan-Meier curves and log-rank tests. Multivariate Cox proportional hazard regressions identified independent predictors of survival.

Results:

We identified 905 patients with uLMS and SILM between 2004 and 2017. 600 patients had primary tumor resection; 63 also had curative intent surgery with metastasectomy. Patients who did not receive chemotherapy were older (p<0.01) with a higher comorbidity index (p<0.05). Women with private health insurance were more likely to receive chemotherapy (p<0.01) and primary tumor resection (p<0.01). Patients who underwent curative intent surgery had 1-year OS of 71.2% and 5-year survival of 18% compared to 1-year survival of 35.6 % and 5-year survival of 5.16 % for patients who had no surgery. Black women had poorer survival on multivariate regression.

Conclusions:

Primary tumor resection and curative intent surgery are associated with improved OS in uLMS with SILM and may be a reasonable treatment option in appropriately selected patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Gynecol Oncol Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Gynecol Oncol Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos